ASC Daily Briefing — August 11, 2026
🆕 New Today
No new items today. See the Standing Compliance Reference for items currently in effect.
Today’s searches surfaced only items already captured on the standing Page or in recent briefings: the CY 2027 OPPS/ASC Proposed Rule (CMS-1850-P, published in the Federal Register July 7, comment deadline August 31, 2026 — proposed 2.4% ASC payment update, ASC CPL additions, IPO-list Year 2 removals, ASCQR measure changes, botulinum-toxin prior-authorization expansion, the AO/EMTALA deeming proposal, and the hospital price-transparency RFI), the CY 2026 OPPS/ASC Final Rule (CMS-1834-FC) in effect (2.6% update, expanded ASC CPL with 560 new procedures, IPO-list phase-out, Extraordinary Circumstances Exception policy), the quarterly payment updates, the Conditions for Coverage at 42 CFR Part 416, the HHS Section 504 accessible MDE baseline (effective July 8, 2026) and extended digital-accessibility deadlines (May 11, 2027 / May 10, 2028), the 10-state ASC prior-authorization demonstration (41 codes), the state CRNA physician-supervision opt-outs (27 states, Ohio added July 10, 2026), AAAHC v44/v45 (v45 educational programs scheduled September 14-16 and December 10-11, 2026), TJC 2026 standards, the five CMS-approved ASC accreditors (AAAHC, ACHC, DNV, TJC, QUAD A), the CMS AO-oversight final rule, and the HHS-OIG 2026 Work Plan.
No new enforcement actions, accreditation announcements, or additional Federal Register ASC notices appeared today. ASC Focus surfaced nothing new dated within the last ~30 days.
Reminder: the CY 2027 Proposed Rule comment deadline (August 31, 2026) is 20 days out. Calendar it now if you’re planning to comment on the proposed 2.4% payment update, the proposed ASC CPL additions, IPO-list Year 2 removals, ASCQR measure changes, or the botulinum-toxin prior-authorization expansion.